Clinical Trial Update: Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery. [NA]

View source ↗

Summary

A clinical trial evaluating frusemide infusion to prevent deterioration of renal function after cardiac surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

Sponsor: Melbourne Health | Conditions: Renal Impairment After Cardiac Surgery | NA | Status: WITHDRAWN